An effectiveness and safety study of herbal extract product comparing to standard treatment in male and female androgenetic alopecia Androgenetic alopecia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Male (Norwood-Hamilton classification of IIa - V) Females (Ludwig classification of I-4, II-1, II-2) No history of allergic reaction following study topical drug used Older than 18 years
Exclusion criteria
Exclusion criteria: -Used the following medications within 6 months prior to screening : minoxidil, finasteride, medication with anti-androgenic properties, estrogen, progesterone, tamoxifen, anabolic steroid and oral contraceptive drugs. -Hair transplant within 1 year -Pregnancy -Breast feeding -Abnormal thyroid function test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| efficacy and safety 6 months Terminal hair/Hair mass index/ 7 rating scalr score/ Pateint-self assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| efficacy 6 months hair count/ clinical assessment | — |
Countries
Thailand
Contacts
Punyananthaphikkhu CHonpratan Medical Center